Uswisi - Kiitaliano - Swissmedic (Swiss Agency for Therapeutic Products)

roche pharma (schweiz) ag - oseltamivirum - capsule - oseltamivirum 30 mg ut oseltamiviri phosphas, amylum pregelificatum, povidonum k 30, carmellosum natricum conexum, talcum, natrii stearylis fumaras, kapselhülle: gelatina, e 171, e 172 (flavum), e 172 (rubrum), drucktinte: lacca, alcohol butylicus, e 171, e 132, ethanolum anhydricum, methanolum, pro capsula corresp. natrium 163.8 µg. - influenza a e b - synthetika

Uswisi - Kiitaliano - Swissmedic (Swiss Agency for Therapeutic Products)

roche pharma (schweiz) ag - oseltamivirum - capsule - oseltamivirum 45 mg ut oseltamiviri phosphas, amylum pregelificatum, povidonum k 30, carmellosum natricum conexum, talcum, natrii stearylis fumaras, kapselhülle: gelatina, e 171, e 172 (nigrum), drucktinte: lacca, alcohol butylicus, e 171, e 132, ethanolum anhydricum, methanolum, pro capsula corresp. natrium 245.8 µg. - influenza a e b - synthetika

Uswisi - Kiitaliano - Swissmedic (Swiss Agency for Therapeutic Products)

novartis pharma schweiz ag - brinzolamidum - augentropfensuspension - brinzolamidum 10 mg, dinatrii edetas, natrii chloridum, mannitolum, tyloxapolum, carbomerum 974p, acidum hydrochloridum aut natrii hydroxidum, aqua purificata, benzalkonii chloridum 100 µg, ad suspensionem pro 1 ml. - il glaucoma, ipertensione okuläre - synthetika

Uswisi - Kiitaliano - Swissmedic (Swiss Agency for Therapeutic Products)

ucb-pharma sa - levetiracetamum - compresse rivestite con film - levetiracetamum 250 mg, carmellosum natricum solo tenuti insieme, macrogolum 6000, silice colloidalis anhydrica, magnesio stearas, poli(alcole vinylicus), macrogolum 3350, talco, e 132, e 171 per compresso haze corrisp. sodio 0,7 mg. - aed - synthetika

Uswisi - Kiitaliano - Swissmedic (Swiss Agency for Therapeutic Products)

ucb-pharma sa - levetiracetamum, sodio - compresse rivestite con film - levetiracetamum 1000 mg, carmellosum natricum solo tenuti insieme, macrogolum 6000, silice colloidalis anhydrica, magnesio stearas, poli(alcole vinylicus), macrogolum 3350, talco, e 171 per compresso haze corrisp. sodio 2,8 mg. - aed - synthetika

Uswisi - Kiitaliano - Swissmedic (Swiss Agency for Therapeutic Products)

ucb-pharma sa - levetiracetamum - compresse rivestite con film - levetiracetamum 500 mg, carmellosum natricum solo tenuti insieme, macrogolum 6000, silice colloidalis anhydrica, magnesio stearas, poli(alcole vinylicus), macrogolum 3350, talco, e 171, e 172 (giallo) per compresso haze corrisp. sodio 1,4 mg. - aed - synthetika

Uswisi - Kiitaliano - Swissmedic (Swiss Agency for Therapeutic Products)

roche pharma (schweiz) ag - oseltamivirum - polvere per sospensione orale - oseltamivirum 6 mg ut oseltamiviri phosphas 7.88 mg, sorbitolum 171.42 mg, xanthani gummi, natrii dihydrogenocitras anhydricus, saccharinum natricum, e 171, e 211 0.5 mg, aromatica, ad pulverem corresp., suspensio reconstituta 1 ml corresp. natrium 1.28 mg. - terapia e profilassi dell'influenza - synthetika

Uswisi - Kiitaliano - Swissmedic (Swiss Agency for Therapeutic Products)

mepha pharma ag - clarithromycinum - granulato per sospensione orale - clarithromycinum 125 mg, poloxamerum 188, povidonum k 30, hypromellosum, macrogolum 6000, acidi methacrylici e ethylis acrylatis polymerisatum 1:1, triethylis citras, glyceroli monostearas 40-55, polysorbatum 80, silice colloidalis anhydrica, xanthani gum sono (fruchtmischung), zucchero 2.4 g, maltodextrinum, e 1450, e 171, e 202, ad granulatum corresp., sospensione reconstituta 5 ml. - malattie infettive - synthetika

Uswisi - Kiitaliano - Swissmedic (Swiss Agency for Therapeutic Products)

mepha pharma ag - clarithromycinum - granulato per sospensione orale - clarithromycinum 250 mg, poloxamerum 188, povidonum k 30, hypromellosum, macrogolum 6000, acidi methacrylici e ethylis acrylatis polymerisatum 1:1, triethylis citras, glyceroli monostearas 40-55, polysorbatum 80, silice colloidalis anhydrica, xanthani gum sono (fruchtmischung), zucchero 2.4 g, maltodextrinum, e 1450, e 171, e 202, ad granulatum corresp., sospensione reconstituta 5 ml. - malattie infettive - synthetika

Uswisi - Kiitaliano - Swissmedic (Swiss Agency for Therapeutic Products)

ucb-pharma sa - levetiracetamum - soluzione buvable - levetiracetamum 100 mg, natrii citras dihydricus, acidum citricum monohydricum, glycerolum (85 per centum), maltitolum liquidum 300 mg, aqua purificata, aromatica, ammonii glycyrrhizas, acesulfamum kalicum, propylis parahydroxybenzoas 0.3 mg, e 218 2.7 mg ad solutionem pro 1 ml corresp. natrium < 23 mg. - antiepileptikum - synthetika